EMA and HMA launch consultation on information in MA application dossiers


The European Medicines Agency and the Heads of Medicines Agencies (HMA) have released a guidance document on the identification of commercially confidential information and protection of personal data within the structure of the marketing-authorisation dossier for public consultation. Public consultation open until 1 September 2011. 


Read more on EMA website. 

Latest News